Cytokines derived from alveolar macrophages induce fever after bronchoscopy and bronchoalveolar lavage

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 5, 1997, Pages 1793-1797

  Krause, Andreas ^a   Hohberg, Beate ^b   Heine, Felicitas ^b   John, Matthias ^b   Burmester, Gerd R ^b   Witt, Christian ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CYTOKINE; GLUCOCORTICOID; HYDROCODONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PRILOCAINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AEROSOL; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; FEVER; FIBEROPTIC BRONCHOSCOPY; FLU LIKE SYNDROME; HUMAN; HUMAN CELL; INHALATIONAL DRUG ADMINISTRATION; INTRATRACHEAL DRUG ADMINISTRATION; LOCAL ANESTHESIA; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MACROPHAGE ACTIVATION; MALE; NEBULIZATION; PREMEDICATION; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

EID: 0030915787     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.5.9154894     Document Type: Article

References (16)

1. Reynolds, H. Y. 1992. Bronchoalveolar lavage has extended the usefulness of bronchoscopy. Eur. Respir. Rev. 2:48-53.
2. Klech, H., W. Pohl, and C. Hutter. 1992. Safety and side-effects of bronchoalveolar lavage. Eur. Respir. Rev. 2:54-57.
3. European Society of Pneumology Task Group on BAL. 1989. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Eur. Respir. J. 2:561-585.
4. The BAL Cooperative Group Steering Committee. 1990. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am. Rev. Respir. Dis. 41(Suppl.):S169-S202.
5. Standiford, T. J., S. L. Kunkel, and R. M. Strieter. 1991. Elevated serum levels of tumor necrosis factor-alpha after bronchoscopy and bronchoalveolar lavage. Chest 99:1529-1530.
6. Reynolds, H. J. 1987. Bronchoalveolar lavage. Am. Rev. Respir. Dis. 135:250-263.
7. Kluger, M. J., W. Kozak, L. R. Leon, D. Soszynki, and C. A. Conn. 1995. Cytokines and fever. Neuroimmunomodulation 2:216-223.
8. American Thoracic Society. 1990. Clinical role of bronchoalveolar lavage in adults with pulmonary disease. Am. Rev. Respir. Dis. 142: 481-486.
9. Burman, S. O. 1960. Bronchoscopy and bacteremia. J. Thorac. Cardiovasc. Surg. 40:635-640.
10. Strumpf, I. J., M. K. Feld, M. J. Cornelius, B. A. Keogh, and R. G. Crystal. 1981. Safety of fiberoptic bronchoalveolar lavage in evaluation of interstitial lung disease. Chest 80:268-271.
11. Dinarello, C. A. 1991. Interleukin-1 and interleukin-1 antagonism. Blood 77:1627-1652.
12. Brach, M. A., and F. Herrmann. 1992. Interleukin 6: presence and future. Int. J. Clin. Lab. Res. 22:143-151.
13. Tracey, K. J., and A. Cerami. 1993. Tumor necrosis factor: an updated review of its biology. Crit. Care Med. 21:8415-422.
14. Kluger, M. J. 1991. Fever: role of pyrogens and cryogens. Physiol. Rev. 71:93-127.
15. Steffen, M., J. Petersen, M. Oldigs, A. Karmeier, H. Magnussen, H. G. Thiele, and A. Raedler. 1993. Increased secretion of tumor necrosis factor-alpha, interleukin-1-beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosis. J. Allergy Clin. Immunol. 91:939-949.
16. Sahashi, K., Y. Ina, K. Takada, T. Sato, M. Yamamoto, and M. Morishita. 1994. Significance of interleukin 6 in patients with sarcoidosis. Chest 106:156-160.